Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine.
Martin DS, Stolfi RL, Sawyer RC. Martin DS, et al. Among authors: sawyer rc. Cancer Chemother Pharmacol. 1989;24(1):9-14. doi: 10.1007/BF00254098. Cancer Chemother Pharmacol. 1989. PMID: 2720896
Chemotherapeutic evaluation using clinical criteria in spontaneous, autochthonous murine breast tumors.
Stolfi RL, Stolfi LM, Sawyer RC, Martin DS. Stolfi RL, et al. Among authors: sawyer rc. J Natl Cancer Inst. 1988 Mar 2;80(1):52-5. doi: 10.1093/jnci/80.1.52. J Natl Cancer Inst. 1988. PMID: 3339639
Quantitation of 5-fluorouracil incorporation into RNA by high-performance liquid chromatography without the use of radioactive precursors.
Sawyer RC, Stolfi RL, Martin DS. Sawyer RC, et al. J Chromatogr. 1989 Nov 24;496(2):450-5. doi: 10.1016/s0378-4347(00)82594-3. J Chromatogr. 1989. PMID: 2613847 No abstract available.
Effect of Uridine on the Metabolism of 5-Fluorouracil in the CD8F 1 Murine Mammary Carcinoma System.
Sawyer RC, Stolfi RL, Spiegelman S, Martin DS. Sawyer RC, et al. Pharm Res. 1984 Mar;1(2):69-75. doi: 10.1023/A:1016351330832. Pharm Res. 1984. PMID: 24277215
Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNA.
Sawyer RC, Stolfi RL, Martin DS, Balis ME. Sawyer RC, et al. Biochem Pharmacol. 1989 Jul 15;38(14):2305-11. doi: 10.1016/0006-2952(89)90470-x. Biochem Pharmacol. 1989. PMID: 2751696
Effect of uridine diphosphoglucose on levels of 5-phosphoribosyl pyrophosphate and uridine triphosphate in murine tissues.
Colofiore JR, Sawyer RC, Balis ME, Martin DS. Colofiore JR, et al. Among authors: sawyer rc. Pharm Res. 1989 Oct;6(10):863-6. doi: 10.1023/a:1015908505351. Pharm Res. 1989. PMID: 2481854
Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer.
Kemeny N, Schneider A, Martin DS, Colofiore J, Sawyer RC, Derby S, Salvia B. Kemeny N, et al. Among authors: sawyer rc. Cancer Res. 1989 Aug 15;49(16):4636-9. Cancer Res. 1989. PMID: 2472883 Free article.
In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy.
Koutcher JA, Sawyer RC, Kornblith AB, Stolfi RL, Martin DS, Devitt ML, Cowburn D, Young CW. Koutcher JA, et al. Among authors: sawyer rc. Magn Reson Med. 1991 May;19(1):113-23. doi: 10.1002/mrm.1910190111. Magn Reson Med. 1991. PMID: 2046526
Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
Sawyer RC, Stolfi RL, Martin DS. Sawyer RC, et al. Cancer Res. 1988 Dec 1;48(23):6664-8. Cancer Res. 1988. PMID: 2460227 Free article.
Improved therapeutic index with sequential N-phosphonacetyl-L-aspartate plus high-dose methotrexate plus high-dose 5-fluorouracil and appropriate rescue.
Martin DS, Stolfi RL, Sawyer RC, Spiegelman S, Young CW. Martin DS, et al. Among authors: sawyer rc. Cancer Res. 1983 Oct;43(10):4653-61. Cancer Res. 1983. PMID: 6603903
34 results
Jump to page